Clinical trial
Phase I Study of Sequential Cord Blood Transplants
NCT00299767 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00299767 |
|---|---|
| Title | Phase I Study of Sequential Cord Blood Transplants |
| Official title | Phase I Study of Sequential Cord Blood Transplants |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Dana-Farber Cancer Institute |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lymphoma, Leukemia, Multiple Myeloma, Myelodysplastic Syndrome |
| Intervention type | Procedure |
| Interventions | sequential cord blood transplantation |
| Enrollment | 21 |
| Start date | May 1, 2003 |
| Primary completion | May 1, 2005 |
| Completion | May 1, 2009 |
| First posted | Mar 7, 2006 |
| Last update posted | May 11, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: